Related Experiment Video

Updated: Sep 30, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs)

Karsten Brand1

  • 1Custos Biotech GmbH, Biomedical Research Campus Berlin-Buch, R. Rössle Str. 10, 13125 Berlin, Germany. KBrand@mdc-Berlin.de

Current Gene Therapy
|July 12, 2002
PubMed

Insights

Tissue inhibitors of metalloproteinases (TIMPs) show therapeutic potential in cancer gene therapy. Overexpression of TIMPs reduces tumor growth and metastasis, with promising results in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Matrix metalloproteinases (MMPs) are critical for tumor invasion and metastasis.
  • Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity.
  • TIMP overexpression has been linked to reduced tumor growth and metastasis.

Purpose of the Study:

  • To review the therapeutic potential of TIMPs in cancer gene therapy.
  • To analyze cell culture and in vivo data regarding TIMP gene transfer.

Main Methods:

  • Review of existing literature on TIMPs and MMPs.
  • Analysis of preclinical data from cell culture and animal models.
  • Focus on gene transfer strategies for TIMP delivery.

Main Results:

  • TIMP overexpression demonstrates antitumor effects.
  • In vivo gene transfer of TIMPs shows efficacy in reducing tumor growth and metastasis.
  • Preclinical studies support the role of TIMPs in cancer treatment.

Conclusions:

  • TIMPs represent a promising target for cancer gene therapy.
  • Gene transfer of TIMPs offers a viable strategy for inhibiting tumor progression.
  • Further research into TIMP-based therapies is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.